Skip to Content
Morningstar

Canopy Growth Corp CGC

Morningstar Rating
Unlock
Stock XNAS Rating as of
$9.05 −0.81 (8.22%)
View Full Chart
As of Delayed Price Closed
Unlock our analysis with Morningstar Investor
Start Free Trial

Company Report

View Archive

Cannabis Shares Rally (Again) on Next Incremental Step to Federal Rescheduling

Kristoffer Inton

Shares of Canadian-licensed producers and US multistate operators rallied massively on news that the US Drug Enforcement Administration will proceed with rescheduling cannabis to Schedule III from Schedule I. Schedule I indicates it is considered to have a high potential for abuse and no medical value. In comparison, Schedule III drugs are considered less dangerous, with a lower potential for abuse and having some medical value. We view the April 30 news as the next step in a long process by the Biden administration to relax the current federal prohibition. We view the market reaction as a reflection of how much pressure these stocks have faced rather than any new development.

Read Full Report

Price vs Fair Value

View History
CGC is trading at a 432% premium.
Price
$9.05
Fair Value
$7.10
Uncertainty
Extreme
1-Star Price
$57.90
5-Star Price
$7.64
Economic Moat
Mkr
Capital Allocation
Nxscx

Bulls Say, Bears Say

Bulls

Canopy Growth’s plans to create Canopy USA to strengthen its competitive position before U.S. federal legalization.

Bears

While Canopy waits for U.S. federal legalization to enter the THC market there, U.S. multistate operators continue to grow bigger and become more competitive.

Show More
Is it the right time to buy, sell, or hold?
Start a free trial of Morningstar Investor to unlock exclusive ratings and continuous analyst coverage to help you decide if CGC is a good fit for your portfolio.
Get 7 Days Free

News

View All

Trading Information

Previous Close Price
$9.86
Day Range
$8.79–10.14
52-Week Range
$2.76–19.20
Bid/Ask
$9.05 / $9.09
Market Cap
$679.22 Mil
Volume/Avg
11.0 Mil / 15.5 Mil

Key Statistics

Price/Earnings (Normalized)
—
Price/Sales
2.66
Dividend Yield (Trailing)
—
Dividend Yield (Forward)
—
Total Yield
—

Company Profile

Canopy Growth, headquartered in Smiths Falls, Canada, cultivates and sells medicinal and recreational cannabis, and hemp, through a portfolio of brands that include Doja, 7ACRES, Tweed, and Deep Space. Its non-THC products include skincare products under Martha Stewart CBD and Storz & Bickel vaporizers. Canopy growth is attempting to merge its U.S. assets into a separately operated holding company, Canopy USA, which will not be consolidated into the Canadian company's financials.
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Stock Style Box
Small Growth
Total Number of Employees
1,621
Website
https://www.canopygrowth.com

Competitors

Valuation

View More
Metric
CGC
CURLF
TLRY
Price/Earnings (Normalized)
 ———
Price/Book Value
 1.833.840.46
Price/Sales
 2.662.961.90
Price/Cash Flow
 —69.75—
Price/Earnings
CGC
CURLF
TLRY

Financial Strength

Metric
CGC
CURLF
TLRY
Quick Ratio
 1.130.310.96
Current Ratio
 1.790.851.92
Interest Coverage
 −9.27−0.24−4.39
Quick Ratio
CGC
CURLF
TLRY

Profitability

Metric
CGC
CURLF
TLRY
Return on Assets (Normalized)
 −23.44%−3.72%−1.42%
Return on Equity (Normalized)
 −57.88%−10.45%−1.82%
Return on Invested Capital (Normalized)
 −20.86%−2.20%−0.92%
Return on Assets
CGC
CURLF
TLRY
See how this stock stacks up to its competitors with Morningstar Investor
Start Free Trial

Drug Manufacturers - Specialty & Generic Industry Comparables

Screen in Investor
Ticker
Name
Morningstar Rating for Stocks
Capital Allocation
Economic Moat
Market Cap
ZTS
Zoetis Inc Class AJvgzgzlntYhqn$77.1 Bil
MKKGY
Merck KGaA ADRNbhhtyrnvmRjvgbb$72.9 Bil
HLN
Haleon PLC ADRFbdjrclsqJrjf$37.5 Bil
VTRS
Viatris IncTvdxbgsmVcxj$13.3 Bil
RDY
Dr Reddy's Laboratories Ltd ADRPvbnmhfrKyfc$11.7 Bil
CTLT
Catalent IncFjmbjhmhHkvyg$10.1 Bil
PRGO
Perrigo Co PLCJqtfplwrVtd$4.2 Bil
CURLF
Curaleaf Holdings IncDkdlqtwvcVmzq$4.0 Bil
PBH
Prestige Consumer Healthcare IncJjwknszDfcxvl$3.5 Bil
GTBIF
Green Thumb Industries IncXdxbxpvhsWygk$3.0 Bil

Sponsor Center